Analytical Data
-
Gene name
C6orf226
- Application
-
Alternative Names
C6orf226Uncharacterized Protein C6orf226
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5I0X4
-
Expression Region
1-101aa
-
AA Sequence
MERPRSPQCS APASASASVT LAQLLQLVQQ GQELPGLEKR HIAAIHGEPT ASRLPRRPKP WEAAALAESL PPPTLRIGTA PAEPGLVEAA TAPSSWHTVG P
-
Molecular Weight
10.5 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C6orf226, also known as chromosome 6 open reading frame 226, is a gene of increasing interest due to its potential implications in various biological processes and diseases. Initially identified through genomic studies, C6orf226 encodes a protein whose precise functions remain largely unexplored. However, emerging research has suggested its involvement in cellular mechanisms such as cell proliferation, differentiation, and apoptosis. Additionally, variations in the expression levels of C6orf226 have been linked to certain pathological conditions, including cancer and autoimmune disorders, highlighting its potential role as a biomarker or therapeutic target. The recombinant expression of C6orf226 protein allows researchers to investigate its biochemical properties, interactions with other cellular components, and effects on signaling pathways. Understanding the structure and function of this protein may provide insights into the underlying mechanisms of associated diseases and contribute to the development of novel diagnostic and treatment strategies. As the scientific community continues to explore the significance of C6orf226, studies utilizing recombinant protein technology are fundamental for elucidating its biological roles and therapeutic potentials.
